ABSTRACT. The in vitro activity of 15 antimicrobial agents against clinical isolates of Staphylococcus pseudintermedius, Staphylococcus aureus, Escherichia coli, Pasteurella spp. and Streptococcus canis from dogs was investigated. For Staphylococcus spp., the highest frequency of resistance was observed for penicillin, followed by ampicillin, tetracycline and chloramphenicol. The highest frequency of resistance in E. coli isolates was recorded for tetracycline and streptomycin. Pasteurella spp. and S. canis had the highest resistance rate for tetracycline and chloramphenicol. Most isolates showed full susceptibility to low-level resistance to colistin, florfenicol and fluoroquinolones. Further studies using larger number of isolates from both healthy and diseased dogs would provide a broader picture of antimicrobial resistance at a national level and promote prudent use of antimicrobial agents in companion animals. Antibacterial drug resistance continues to increase worldwide, with some pathogenic bacteria exhibiting resistance to virtually all available drugs [29]. While there are considerable, though often fragmented, data on the quantities of antimicrobial drug use and resistance in bacteria of food animal origin, useful data on antimicrobial drug use and resistance in companion animals are relatively scarce [22,24]. The most frequent bacterial infections in dogs include skin, ear, wound, gastrointestinal and urinary tract infections. Staphylococcus pseudintermedius, Escherichia coli, Pseudomonas aeruginosa, Streptococcus spp. and Proteus spp. are among the most frequently encountered bacterial pathogens in companion animal veterinary practice. The antimicrobial drug susceptibilities of canine isolates have been reported [1,7,9,23], most of which have also zoonotic significance. S. pseudintermedius is the principal cause of pyoderma and otitis in canine [24]. Although it had been misidentified for decades as S. intermedius, recent analyses by molecular phylogenetic and PCR-restriction fragment length polymorphism (PCR-RFLP) approaches indicated that S. pseudintermedius, not S. intermedius, is the major canine pyoderma pathogen [6,23,25], and it has already been proposed that all strains from dogs identified by traditional means be reported as S. pseudintermedius [6,11]. Increasing resistance of this organism and failures to treat canine pyoderma or otitis with a number of antibacterial agents, including fluoroquinolones were reported recently [6,30]. Furthermore, cross-resistance between fluoroquinolones and other antibacterial agents and zoonotic transmission of both meticillin-susceptible and meticillin-resistant S. pseudintermedius between dogs and humans have been concerns recently [30,31]. Resistance in canine E. coli isolates to a wide range of antimicrobial agents, including fluoroquinolones, is increasingly reported [2]. Furthermore, the chemical and structural similarities between veterinary and human-use drugs and the close phylogenetic relationships between E. coli isolates from dogs and man have r...